Monday , 6 April 2020


Cannabis Central: Ignore the Hype, Ignore the Lies!

According to the CannabisInvestor.Ca most experts are supposedly in agreement that, after multiple failed bottoming attempts, the cannabis market is at its bottom. CannabisInvestor.Ca goes on to falsely claim that cannabis stocks roared back to life last week with many pot stocks posting 20% – 60% weekly gains. Unfortunately, however, that statement can not be supported by the facts and, as such, it is nothing more than totally misleading HYPE - a lie.

Read More »

Beware! Convertible Debenture Debt Situation With These 10 Cannabis Companies Is Dire

Many convertible debentures were issued in 2018 on two year terms by companies in the cannabis sector are about to come due with conversion prices for this debt far above current equity prices in many instances. As a result, the current environment has seen suppressed share prices as few large investors wish to get into high-risk investments. To highlight how dire the current situation is, we’ve compiled a list of several issuers below that are currently in precarious situations as a result of their current debt load and the likely inability to currently pay off the debt under current cash reserves.

Read More »

Americans: Use CUSIP Numbers When Buying Canadian Exchange Listed Cannabis Stocks – Here’s Why & How

It is easy for Canadian investors to execute orders for cannabis stocks using their Canadian symbol but it is not as straight forward for those individuals (i.e. Americans) using non-Canadian brokerage houses because many brokerage houses and online brokers don't know the symbols for the cannabis penny stocks you might wish to buy. That's where the use of CUSIP numbers can be very helpful.

Read More »

Vireo Health Q3 Financial Report Downplays Abysmal Comparison To Q2

Like so many other struggling marijuana companies that don't have much of a positive nature to report about their latest quarterly financial and operational performance management often hypes how well they are doing compared to the same period a year ago instead of the previous quarter. That is exactly what the management of Vireo Health International has done. This article corrects that misdirection.

Read More »

Auxly Cannabis Spins Q3 Financial Results

Auxly Cannabis Group Inc. (TSX.V:XLY; OTCQX:CBWTF; CUSIP#: 05335P 11 7) reported its Q3 financial results on Friday (Nov.22) for the 3 months ended Sept. 30/2019 in a manner which presented a positive spin on the quarter's performance - "This has been an incredible quarter for Auxly" according to CEO, Hugo Alves - but it is hardly reflective as to how the company has been evolving of late.

Read More »